Figure 1From: Development of a non-invasive fibrosis test for chronic hepatitis B patients and comparison with other unpatented scoresPerformance of the HB-F fibrosis score in the training cohort of patients. (A) The ranges of HB-F scores in patients with different ISHAK fibrosis score (FS1-FS6). Gray boxes represented the 25%-75% quartiles; The middle horizontal lines represented the median scores. (B) The ranges of HB-F scores in subjects stratified by FSā<ā5 (non-cirrhotic patients) and FSā>ā=5 (cirrhosis) (Pā<ā0.001). (C) The ranges of HB-F scores in subjects grouped by FSā<ā4 and FSā>ā=4 (prominent fibrosis) (Pā<ā0.001). (D) The ROC curve of the HB-F score for the diagnosis of cirrhosis patients (AUCā=ā0.799). (E) The ROC curve for the diagnosis of prominent fibrosis patients (AUCā=ā0.810).Back to article page